70 Participants Needed

Mindful Attention Training for Pediatric Cancer Survivors

CL
JA
CG
JA
Overseen ByJoaquin Anguera, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This pilot study will evaluate the cognitive and behavioral outcomes of using a novel, adaptive attention training in pediatric cancer survivors.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are on cancer-related treatments, it will be discussed with the study team to see if it affects your participation.

What data supports the effectiveness of the treatment Mindful Attention Training for Pediatric Cancer Survivors?

Research shows that attention training can help improve attention in children who have survived cancer, with studies indicating improvements in attention measures. A cognitive remediation program for cancer survivors showed significant improvement in attention, suggesting that similar attention-focused treatments could be beneficial.12345

Is Mindful Attention Training safe for children, including those who have survived cancer?

The studies reviewed suggest that attention training programs, including computerized cognitive training, have been used safely in children, including those who have survived cancer. These programs have shown good feasibility and acceptability, with no significant safety concerns reported.45678

How is Novel Mindful Attention Training different from other treatments for pediatric cancer survivors?

Novel Mindful Attention Training is unique because it focuses on improving attention and cognitive functions through mindfulness techniques, which is different from traditional treatments that may not specifically target attention issues. This approach is particularly relevant for pediatric cancer survivors who often experience attention problems due to their illness or treatment.34689

Research Team

JA

Joaquin Anguera, PhD

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for children aged 7-17 who have survived pediatric cancer, can follow the study's procedures, and have a guardian to consent. They should speak English fluently, not be on certain cancer treatments that affect participation, and must have had radiation therapy to the brain or neck.

Inclusion Criteria

My vision and hearing are normal, or corrected to normal.
I am between 7 and 17 years old.
I, and if applicable, my legal guardian, can understand and are willing to sign the informed consent document.
See 4 more

Exclusion Criteria

Current cancer-related treatments that would impact the ability to participate in the study (e.g., current inpatient chemotherapy or intrathecal chemotherapy). Patients on other current treatments will be discussed with the study team (co-PI, Dr. Mueller)
Contraindication to any study-related procedure or assessment
You have difficulty using a computer or tablet due to problems with moving or understanding things.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants complete adaptive attention training ('Engage') for 6-8 weeks, with randomized cohorts completing either 15 hours or 1 hour of training.

6-8 weeks

Follow-up

Participants are monitored for cognitive and behavioral outcomes after completing the training.

4 weeks

No Contact Group Assessment

Participants in the no-contact group complete baseline and end-of-study assessments to evaluate assessment feasibility and reliability.

6-8 weeks

Treatment Details

Interventions

  • Novel Mindful Attention Training
Trial OverviewThe study tests an adaptive attention training program against standard questionnaires to see if it improves thinking skills and behavior in kids who've beaten cancer. It's a pilot study which means it's preliminary research before larger studies.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: No Contact Group (Not Randomized)Experimental Treatment1 Intervention
An additional thirty participants will be enrolled separately (not randomized) into the no-contact group. Participants in the no-contact group will not complete any study activities for 6-8 weeks after completing the baseline assessments. After this period, participants will be prompted to log into Nexus to complete end of study assessments (same set of assessments administered/completed at baseline).
Group II: Adaptive Attention TrainingExperimental Treatment2 Interventions
Participants will complete approximately 15 hours of an at-home training on a novel adaptive attention training program ('Engage'), which will consist of completing thirty, 30-minute sessions over a total of 6-8 weeks.
Group III: Low-dose Adaptive Attention TrainingActive Control2 Interventions
Participants will complete approximately 1 hour of at-home training on 'Engage' which consists of two, 30-minute sessions at the beginning and middle of a 6-8 week period.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

Findings from Research

About 28% of pediatric cancer survivors experience significant daytime sleepiness, which is linked to poorer neurobehavioral outcomes such as inattention, hyperactivity, and anxiety, as reported by both parents and teachers.
The study highlights the importance of assessing sleep functioning in annual care for cancer survivors, as sleep issues can negatively impact their behavior and emotional well-being in both home and school settings.
Sleep and neurobehavioral functioning in survivors of pediatric cancer.Oswald, KA., Richard, A., Hodges, E., et al.[2021]
In a study of 29 children who underwent surgery for brain tumors, both those treated with radiation therapy (RT) and those who were not showed similar levels of attention performance and parent ratings at follow-up, suggesting that RT may not significantly impact attention outcomes in this group.
However, children with infratentorial tumors exhibited more inattention and inhibitory control errors on an auditory attention test compared to those with supratentorial tumors, indicating that tumor location plays a critical role in cognitive outcomes post-surgery.
Performance-based and parent ratings of attention in children treated for a brain tumor: The significance of radiation therapy and tumor location on outcome.Raghubar, KP., Mahone, EM., Yeates, KO., et al.[2019]
In a study of 33 pediatric medulloblastoma survivors aged 7-18, parent-reported attention problems were significantly linked to social functioning, indicating that attention deficits can impact social skills in these survivors.
Self-reported attention ratings did not correlate with social functioning, suggesting that parents may have a better perspective on their child's attention issues compared to the children's self-assessment.
Impact of attention on social functioning in pediatric medulloblastoma survivors.Holland, AA., Colaluca, B., Bailey, L., et al.[2018]

References

Sleep and neurobehavioral functioning in survivors of pediatric cancer. [2021]
Performance-based and parent ratings of attention in children treated for a brain tumor: The significance of radiation therapy and tumor location on outcome. [2019]
Impact of attention on social functioning in pediatric medulloblastoma survivors. [2018]
Remediation of attention deficits in children: a focus on childhood cancer, traumatic brain injury and attention deficit disorder. [2007]
Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. [2022]
Computerized cognitive training in survivors of childhood cancer: a pilot study. [2023]
Cognitive training programs for childhood cancer patients and survivors: A critical review and future directions. [2018]
[Formula: see text]The contribution of sluggish cognitive tempo to processing speed in survivors of pediatric brain tumors. [2021]
Intellectual functioning and multi-dimensional attentional processes in long-term survivors of a central nervous system related pediatric malignancy. [2013]